+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Next Generation Sequencing Market Report 2024-2034

  • PDF Icon

    Report

  • 301 Pages
  • October 2024
  • Region: Global
  • Visiongain
  • ID: 5852476
Description Jump to:
Overall world revenue for the Next Generation Sequencing Market: In terms of value the market will surpass US$8.0 billion in 2024, the work calculates. The publisher predicts strong revenue growth through to 2034.Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The Next Generation Sequencing Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Research and Clinical Collaborations are Expected to Enhance the NGS Market

Research and clinical collaborations are likely to play a significant role in augmenting the next generation sequencing (NGS) market. These collaborations can drive innovation, reduce costs, and expand the application of NGS technologies. Collaborations bring together experts from various fields, such as genomics, bioinformatics, clinical medicine, and data science, fostering interdisciplinary innovation. A rising number of NGS industry players are developing partnerships with major diagnostics and pharmaceutical businesses, which is a key step towards furthering the use of NGS in clinical settings and personalised medicine. For instance, on 5th January 2024, Illumina Inc., a global pioneer in DNA sequencing and array-based technologies, said that it has entered into a collaboration with Janssen Research & Development, LLC. This will be the first cooperation to create Illumina, Inc. revolutionary molecular residual disease assay, a WGS (whole-genome sequencing) multi-cancer research service that can detect circulating tumour DNA (ctDNA) to better understand disease persistence or recurrence following clinical intervention.

Pricing Pressure has Emerged as a Significant Barrier to the Growth of the Next-Generation Sequencing Market.

Pricing pressure is a significant restraint on the global expansion of the next generation sequencing (NGS) sector. Intense rivalry among prominent NGS providers has caused price wars, which can pressure corporate margins. Emerging companies and alternative sequencing technologies (e.g., nanopore sequencing) further increase competition, forcing existing players to lower prices to remain competitive. Since biopharmaceutical companies are cautious to invest in the discovery of novel drugs, the global clinical research market is currently seeing slow growth. Price pressure is increasing the use of generic medications, which is likely to slow R&D investment growth. Due to easy access to prescriptions, the usage of generic drugs is rapidly increasing over the world. This is projected to have a negative impact on clinical research industry expansion, affecting the NGS market.

Key Questions Answered

  • How is the next generation sequencing market evolving?
  • What is driving and restraining the next generation sequencing market?
  • How will each next generation sequencing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each next generation sequencing submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading next generation sequencing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the next generation sequencing projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of next generation sequencing projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the next generation sequencing manufacturing market?
  • Where is the next generation sequencing market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the next generation sequencing market today, and over the next 10 years:

  • This 301-page report provides 118 tables and 185 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them ‚Äì NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2034 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2034, the new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising vaccine contract manufacturing prices and recent developments.

Segments Covered in the Report

Type

  • Consumables
  • Bioinformatics
  • Sequencing Services
  • Whole Exome Sequencing
  • Targeted Panels
  • Whole-genome Sequencing
  • Others
  • Pre-sequencing Services
  • Library Preparation and Target Enrichment
  • Quality Control
  • Instruments

Workflow

  • Library Preparation
  • Semi-automated
  • Automated
  • Sequencing
  • Data Analysis
  • NGS Primary Data Analysis
  • NGS Secondary Data Analysis
  • NGS Tertiary Data Analysis

Application

  • Oncology
  • Diagnostics and Screening
  • Research Studies
  • Reproductive Health
  • NIPT (Noninvasive Prenatal Testing)
  • PGT (Preimplantation Genetic Testing)
  • Newborn Genetic Screening
  • Single Gene Analysis
  • Genetic and Rare Diseases
  • Consumer Genomics
  • Agrigenomics & Forensics
  • Others

End-use

  • Hospitals and Clinics
  • Academic and Research Institutes
  • Pharmaceutical and Biotech Companies
  • Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Denmark
  • Norway
  • Sweden
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Thailand
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Turkey
  • Rest of MEA
The report also includes profiles for some of the leading companies in the Next Generation Sequencing Market, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

  • Illumina, Inc.
  • F. Hoffman-La Roche Ltd.
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Eurofins Scientific
  • Agilent Technologies
  • Tecan Group
  • Takara Bio
  • 10x Genomics
  • GenScript
  • Integrated DNA Technologies
  • Oxford Nanopore Technologies

How will the Next Generation Sequencing Market report help you?

In summary, the 300+ page report provides you with the following knowledge:
  • Revenue forecasts to 2034 for Next Generation Sequencing Market 2024 to 2034, with forecasts for type, workflow, application, and end-use, each forecast at a global and regional level ‚Äì discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 20 key national markets ‚Äì See forecasts for the Next Generation Sequencing Market market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Colombia, Germany, France, UK, Italy, Spain, Denmark, Norway, Sweden, China, India, Japan, Singapore, South Korea, Thailand, GCC Countries, South Africa, Turkey, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market ‚Äì including company profiles for 14 of the major companies involved in the Next Generation Sequencing Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Next Generation Sequencing Market, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Next Generation Sequencing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Rapid Technological Advancements is Boosting the NGS Market to Grow
3.3.1.2 Research and Clinical Collaborations is Likely to Augment the NGS market
3.3.1.3 Increasing Healthcare Spending
3.3.1.4 Growing Disease Variation and Prevalence is Contributing to the Growing NGS Technology Demand
3.3.2 Market Restraining Factors
3.3.2.1 Lack of Skilled Professionals is Hampering the Market Growth
3.3.2.2 Pricing Pressure Becomes one of the Main Obstacles to the Expansion of the Global Next Generation Sequencing
3.3.2.3 Privacy and Ethical Challenges
3.3.3 Market Opportunities
3.3.3.1 Personalised Medicine and Precision Oncology Creates a Huge Opportunity for the Market to Grow
3.3.3.2 Adoption of NGS in Biomarker Discovery and Drug Development as NGS have Accelerated the Development of Targeted Therapies
3.4 Supply Chain Analysis
3.5 Regulatory Framework
3.6 Emerging Markets and Megatrends
3.7 Porter's Five Forces Analysis
3.7.1 Bargaining Power of Suppliers
3.7.2 Bargaining Power of Buyers
3.7.3 Competitive Rivalry
3.7.4 Threat of Substitutes
3.7.5 Threat of New Entrants
3.8 PESTLE Analysis
4 Next Generation Sequencing Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.2.1 Next Generation Sequencing Market Size Estimation and Forecast by Type
4.3 Consumables
4.3.1 Market Size by Region, 2024-2034 (US$ Billion)
4.3.2 Market Share by Region, 2024 & 2034 (%)
4.4 Bioinformatics
4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Sequencing Services
4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Pre-Sequencing Services
4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Instruments
4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
4.7.2 Market Share by Region, 2024 & 2034 (%)
5 Next Generation Sequencing Market Analysis by Workflow
5.1 Key Findings
5.2 Workflow Segment: Market Attractiveness Index
5.2.1 Next Generation Sequencing Market Size Estimation and Forecast by Workflow
5.3 Library preparation
5.3.1 Market Size by Region, 2024-2034 (US$ Billion)
5.3.2 Market Share by Region, 2024 & 2034 (%)
5.4 Sequencing
5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Data Analysis
5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
5.5.2 Market Share by Region, 2024 & 2034 (%)
6 Next Generation Sequencing Market Analysis by Application
6.1 Key Findings
6.2 Application Segment: Market Attractiveness Index
6.2.1 Next Generation Sequencing Market Size Estimation and Forecast by Application
6.3 Oncology
6.3.1 Market Size by Region, 2024-2034 (US$ Billion)
6.3.2 Market Share by Region, 2024 & 2034 (%)
6.4 Reproductive Health
6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Genetic and Rare Diseases
6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Consumer Genomics
6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.7 Agrigenomics & Forensics
6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
6.7.2 Market Share by Region, 2024 & 2034 (%)
6.8 Others
6.8.1 Market Size by Region, 2024-2034 (US$ Billion)
6.8.2 Market Share by Region, 2024 & 2034 (%)
7 Next Generation Sequencing Market Analysis by End-use
7.1 Key Findings
7.2 End-use Segment: Market Attractiveness Index
7.2.1 Next Generation Sequencing Market Size Estimation and Forecast by End-use
7.3 Hospitals and Clinics
7.3.1 Market Size by Region, 2024-2034 (US$ Billion)
7.3.2 Market Share by Region, 2024 & 2034 (%)
7.4 Academic and Research Institutes
7.4.1 Market Size by Region, 2024-2034 (US$ Billion)
7.4.2 Market Share by Region, 2024 & 2034 (%)
7.5 Pharmaceutical and Biotech Companies
7.5.1 Market Size by Region, 2024-2034 (US$ Billion)
7.5.2 Market Share by Region, 2024 & 2034 (%)
7.6 Others
7.6.1 Market Size by Region, 2024-2034 (US$ Billion)
7.6.2 Market Share by Region, 2024 & 2034 (%)
8 Next Generation Sequencing Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America Next Generation Sequencing Market Analysis
9.1 Key Findings
9.2 North America Next Generation Sequencing Market Attractiveness Index
9.3 North America Next Generation Sequencing Market by Country, 2024, 2029 & 2034 (US$ Billion)
9.4 North America Next Generation Sequencing Market Size Estimation and Forecast by Country
9.5 North America Next Generation Sequencing Market Size Estimation and Forecast by Type
9.6 North America Next Generation Sequencing Market Size Estimation and Forecast by Workflow
9.7 North America Next Generation Sequencing Market Size Estimation and Forecast by Application
9.8 North America Next Generation Sequencing Market Size Estimation and Forecast by End-use
9.9 U.S. Next Generation Sequencing Market Analysis
9.10 Canada Next Generation Sequencing Market Analysis
10 Europe Next Generation Sequencing Market Analysis
10.1 Key Findings
10.2 Europe Next Generation Sequencing Market Attractiveness Index
10.3 Europe Next Generation Sequencing Market by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 Europe Next Generation Sequencing Market Size Estimation and Forecast by Country
10.5 Europe Next Generation Sequencing Market Size Estimation and Forecast by Type
10.6 Europe Next Generation Sequencing Market Size Estimation and Forecast by Workflow
10.7 Europe Next Generation Sequencing Market Size Estimation and Forecast by Application
10.8 Europe Next Generation Sequencing Market Size Estimation and Forecast by End-use
10.9 Germany Next Generation Sequencing Market Analysis
10.10 France Next Generation Sequencing Market Analysis
10.11 UK Next Generation Sequencing Market Analysis
10.12 Italy Next Generation Sequencing Market Analysis
10.13 Spain Next Generation Sequencing Market Analysis
10.14 Russia Next Generation Sequencing Market Analysis
10.15 Denmark Next Generation Sequencing Market Analysis
10.16 Sweden Next Generation Sequencing Market Analysis
10.17 Norway Next Generation Sequencing Market Analysis
10.18 Rest of Europe Next Generation Sequencing Market Analysis
11 Asia Pacific Next Generation Sequencing Market Analysis
11.1 Key Findings
11.2 Asia Pacific Next Generation Sequencing Market Attractiveness Index
11.3 Asia Pacific Next Generation Sequencing Market by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 Asia Pacific Next Generation Sequencing Market Size Estimation and Forecast by Country
11.5 Asia Pacific Next Generation Sequencing Market Size Estimation and Forecast by Type
11.6 Asia Pacific Next Generation Sequencing Market Size Estimation and Forecast by Workflow
11.7 Asia Pacific Next Generation Sequencing Market Size Estimation and Forecast by Application
11.8 Asia Pacific Next Generation Sequencing Market Size Estimation and Forecast by End-use
11.9 Japan Next Generation Sequencing Market Analysis
11.10 China Next Generation Sequencing Market Analysis
11.11 India Next Generation Sequencing Market Analysis
11.12 Australia Next Generation Sequencing Market Analysis
11.13 South Korea Next Generation Sequencing Market Analysis
11.14 Singapore Next Generation Sequencing Market Analysis
11.15 Thailand Next Generation Sequencing Market Analysis
11.16 Rest of Asia Pacific Next Generation Sequencing Market Analysis
12 Latin America Next Generation Sequencing Market Analysis
12.1 Key Findings
12.2 Latin America Next Generation Sequencing Market Attractiveness Index
12.3 Latin America Next Generation Sequencing Market by Country, 2024, 2029 & 2034 (US$ Billion)
12.4 Latin America Next Generation Sequencing Market Size Estimation and Forecast by Country
12.5 Latin America Next Generation Sequencing Market Size Estimation and Forecast by Type
12.6 Latin America Next Generation Sequencing Market Size Estimation and Forecast by Workflow
12.7 Latin America Next Generation Sequencing Market Size Estimation and Forecast by Application
12.8 Latin America Next Generation Sequencing Market Size Estimation and Forecast by End-use
12.9 Brazil Next Generation Sequencing Market Analysis
12.10 Mexico Next Generation Sequencing Market Analysis
12.11 Argentina Next Generation Sequencing Market Analysis
12.12 Colombia Next Generation Sequencing Market Analysis
12.13 Rest of Latin America Next Generation Sequencing Market Analysis
13 MEA Next Generation Sequencing Market Analysis
13.1 Key Findings
13.2 MEA Next Generation Sequencing Market Attractiveness Index
13.3 MEA Next Generation Sequencing Market by Country, 2024, 2029 & 2034 (US$ Billion)
13.4 MEA Next Generation Sequencing Market Size Estimation and Forecast by Country
13.5 MEA Next Generation Sequencing Market Size Estimation and Forecast by Type
13.6 MEA Next Generation Sequencing Market Size Estimation and Forecast by Workflow
13.7 MEA Next Generation Sequencing Market Size Estimation and Forecast by Application
13.8 MEA Next Generation Sequencing Market Size Estimation and Forecast by End-use
13.9 GCC Countries Next Generation Sequencing Market Analysis
13.10 South Africa Next Generation Sequencing Market Analysis
13.11 Turkey Next Generation Sequencing Market Analysis
13.12 Rest of MEA Next Generation Sequencing Market Analysis
14 Company Profiles
14.1 Competitive Landscape, 2023
14.2 Strategic Outlook
14.3 Illumina, Inc.
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2019-2023
14.3.3.2 R&D, 2019-2023
14.3.3.3 Business Segment Market Shares, 2023
14.3.3.4 Regional Market Shares, 2023
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.3.6 SWOT Analysis
14.4 F. Hoffmann-La Roche Ltd.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2019-2023
14.4.3.2 R&D, 2019-2023
14.4.3.3 Business Segment Market Shares, 2023
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.4.6 SWOT Analysis
14.5 QIAGEN
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2019-2023
14.5.3.2 Business Segment Market Shares, 2023
14.5.3.3 Regional Market Shares, 2023
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.5.6 SWOT Analysis
14.6 Thermo Fisher Scientific Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2019-2023
14.6.3.2 Business Segment Market Shares, 2023
14.6.3.3 Regional Market Shares, 2023
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.6.6 SWOT Analysis
14.7 Bio-Rad Laboratories, Inc.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2019-2023
14.7.3.2 Regional Market Shares, 2023
14.7.3.3 Business Segment Market Shares, 2023
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.7.6 SWOT Analysis
14.8 PerkinElmer Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.8.4 Strategic Outlook
14.8.5 SWOT Analysis
14.9 Eurofins Scientific
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2019-2023
14.9.3.2 Regional Market Shares, 2023
14.9.3.3 Business Segment Market Shares, 2023
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.9.6 SWOT Analysis
14.10 Tecan Group
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2019-2023
14.10.3.2 Regional Market Shares, 2023
14.10.3.3 Business Segment Market Shares, 2023
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Takara Bio
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2019-2023
14.11.3.2 R&D, 2019-2023
14.11.3.3 Regional Market Shares, 2023
14.11.3.4 Business Segment Market Shares, 2023
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 10x Genomics
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2019-2023
14.12.3.2 Business Segment Market Shares, 2023
14.12.3.3 Region Market Shares, 2023
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 GenScript
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2019-2023
14.13.4 Product Benchmarking
14.13.5 Strategic Outlook
14.14 Integrated DNA Technologies
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.14.4 Strategic Outlook
14.15 Oxford Nanopore Technologies
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2019-2023
14.15.4 Product Benchmarking
14.15.5 Strategic Outlook
15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations for Market Players
List of Tables
Table 1 Next Generation Sequencing Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 3 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 4 Bioinformatics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 5 Sequencing Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 6 Pre-Sequencing Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 7 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 8 Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 9 Library Preparation Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 10 Sequencing Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 11 Data Analysis Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 12 Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 13 Oncology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 14 Reproductive Health Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 15 Genetic and Rare Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 16 Consumer Genomics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 17 Agrigenomics & Forensics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 18 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 19 Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 20 Hospitals and Clinics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 21 Academic and Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 22 Pharmaceutical and Biotech Companies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 23 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 24 Next Generation Sequencing Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 25 North America Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 26 North America Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 27 North America Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 28 North America Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 29 North America Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 30 U.S. Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 31 Canada Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 32 Europe Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 33 Europe Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 34 Europe Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 35 Europe Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 36 Europe Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 37 Germany Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 38 France Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 39 UK Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 40 Italy Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 41 Spain Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 42 Russia Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 43 Denmark Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 44 Sweden Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 45 Norway Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 46 Rest of Europe Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 47 Asia Pacific Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 48 Asia Pacific Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 49 Asia Pacific Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 50 Asia Pacific Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 51 Asia Pacific Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 52 Japan Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 53 China Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 54 India Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 55 Australia Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 56 South Korea Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 57 Singapore Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 58 Thailand Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 59 Rest of Asia Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 60 Latin America Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 61 Latin America Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 62 Latin America Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 63 Latin America Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 64 Latin America Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 65 Brazil Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 66 Mexico Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 67 Argentina Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 68 Colombia Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 69 Rest of Latin America Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 70 MEA Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 71 MEA Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 72 MEA Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 73 MEA Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 74 MEA Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 75 GCC Countries Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 76 South Africa Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 77 Turkey Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 78 Rest of MEA Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 79 Strategic Outlook
Table 80 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Illumina Inc.: Product Benchmarking
Table 82 Illumina Inc.: Strategic Outlook
Table 83 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 85 F. Hoffmann-La Roche Ltd.: Strategic Outlook
Table 86 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 QIAGEN: Product Benchmarking
Table 88 QIAGEN: Strategic Outlook
Table 89 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 91 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 92 Bio-Rad Laboratories, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Bio-Rad Laboratories, Inc.: Product Benchmarking
Table 94 Bio-Rad Laboratories, Inc.: Strategic Outlook
Table 95 PerkinElmer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 PerkinElmer Inc.: Product Benchmarking
Table 97 PerkinElmer Inc.: Strategic Outlook
Table 98 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Eurofins Scientific: Product Benchmarking
Table 100 Eurofins Scientific: Strategic Outlook
Table 101 Tecan Group.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Tecan Group: Product Benchmarking
Table 103 Tecan Group: Strategic Outlook
Table 104 Takara Bio: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Takara Bio: Product Benchmarking
Table 106 Takara Bio: Strategic Outlook
Table 107 10x Genomics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 10x Genomics: Product Benchmarking
Table 109 10x Genomics: Strategic Outlook
Table 110 GenScript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 GenScript: Product Benchmarking
Table 112 GenScript: Strategic Outlook
Table 113 Integrated DNA Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Integrated DNA Technologies: Product Benchmarking
Table 115 Integrated DNA Technologies: Strategic Outlook
Table 116 Oxford Nanopore Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Oxford Nanopore Technologies: Product Benchmarking
Table 118 Oxford Nanopore Technologies: Strategic Outlook
List of Figures
Figure 1 Next Generation Sequencing Market Segmentation
Figure 2 Next Generation Sequencing Market by Type: Market Attractiveness Index
Figure 3 Next Generation Sequencing Market by Workflow: Attractiveness Index by Workflow
Figure 4 Next Generation Sequencing Market Attractiveness Index by Application
Figure 5 Next Generation Sequencing Market Attractiveness Index by End-use
Figure 6 Next Generation Sequencing Market Attractiveness Index by Region
Figure 7 Next Generation Sequencing Market: Market Dynamics
Figure 8 Next Generation Sequencing Market: Impact Analysis
Figure 9 Pharma Industry: Supply Chain Analysis
Figure 10 Next Generation Sequencing Market: Porter's Five Forces Analysis
Figure 11 Next Generation Sequencing Market: PESTLE Analysis
Figure 12 Next Generation Sequencing Market by Type: Market Attractiveness Index
Figure 13 Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 14 Next Generation Sequencing Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 15 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 16 Consumables Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 17 Bioinformatics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 18 Bioinformatics Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 19 Sequencing Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 20 Sequencing Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Pre-Sequencing Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 22 Pre-Sequencing Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 24 Instruments Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Next Generation Sequencing Market by Workflow: Market Attractiveness Index
Figure 26 Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %)
Figure 27 Next Generation Sequencing Market Share Forecast by Workflow, 2024, 2029, 2034 (%)
Figure 28 Library Preparation Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 29 Library Preparation Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 30 Sequencing Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 31 Sequencing Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 32 Data Analysis Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 33 Data Analysis Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 34 Next Generation Sequencing Market by Application: Market Attractiveness Index
Figure 35 Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 36 Next Generation Sequencing Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 37 Oncology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 38 Oncology Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 39 Reproductive Health Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 40 Reproductive Health Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 41 Genetic and Rare Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 42 Genetic and Rare Diseases Market Share Forecast by Region, 2024 & 2034 (%)
Figure 43 Consumer Genomics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 44 Consumer Genomics Market Share Forecast by Region, 2024 & 2034 (%)
Figure 45 Agrigenomics & Forensics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 46 Agrigenomics & Forensics Market Share Forecast by Region, 2024 & 2034 (%)
Figure 47 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 48 Others Market Share Forecast by Region, 2024 & 2034 (%)
Figure 49 Next Generation Sequencing Market by End-use: Market Attractiveness Index
Figure 50 Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %)
Figure 51 Next Generation Sequencing Market Share Forecast by Indication, 2024, 2029, 2034 (%)
Figure 52 Hospitals and Clinics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 53 Hospitals and Clinics Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 54 Academic and Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 55 Academic and Research Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 56 Pharmaceutical and Biotech Companies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 57 Pharmaceutical and Biotech Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 58 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 59 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 60 Next Generation Sequencing Market Forecast by Region 2024 and 2034 (Revenue, CAGR %)
Figure 61 Next Generation Sequencing Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 62 Next Generation Sequencing Market by Region, 2024-2034 (US$ Billion, AGR %)
Figure 63 North America Next Generation Sequencing Market Attractiveness Index
Figure 64 North America Next Generation Sequencing Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 65 North America Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 66 North America Next Generation Sequencing Market Share Forecast by Country, 2024 & 2034 (%)
Figure 67 North America Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 68 North America Next Generation Sequencing Market Share Forecast by Type, 2024 & 2034 (%)
Figure 69 North America Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %)
Figure 70 North America Next Generation Sequencing Market Share Forecast by Workflow, 2024 & 2034 (%)
Figure 71 North America Next Generation Sequencing Market Share Forecast by Application, 2024 & 2034 (%)
Figure 72 North America Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %)
Figure 73 North America Next Generation Sequencing Market Share Forecast by End-use, 2024 & 2034 (%)
Figure 74 U.S. Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 75 Canada Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 76 Europe Next Generation Sequencing Market Attractiveness Index
Figure 77 Europe Next Generation Sequencing Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 78 Europe Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 79 Europe Next Generation Sequencing Market Share Forecast by Country, 2024 & 2034 (%)
Figure 80 Europe Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 81 Europe Next Generation Sequencing Market Share Forecast by Type, 2024 & 2034 (%)
Figure 82 Europe Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %)
Figure 83 Europe Next Generation Sequencing Market Share Forecast by Workflow, 2024 & 2034 (%)
Figure 84 Europe Next Generation Sequencing Market Share Forecast by Application, 2024 & 2034 (%)
Figure 85 Europe Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %)
Figure 86 Europe Next Generation Sequencing Market Share Forecast by End-use, 2024 & 2034 (%)
Figure 87 Germany Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 88 France Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 89 UK Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 90 Italy Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 91 Spain Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 92 Russia Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 93 Denmark Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 94 Sweden Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 95 Norway Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 96 Rest of Europe Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 97 Asia Pacific Next Generation Sequencing Market Attractiveness Index
Figure 98 Asia Pacific Next Generation Sequencing Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 99 Asia Pacific Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 100 Asia Pacific Next Generation Sequencing Market Share Forecast by Country, 2024 & 2034 (%)
Figure 101 Asia Pacific Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 102 Asia Pacific Next Generation Sequencing Market Share Forecast by Type, 2024 & 2034 (%)
Figure 103 Asia Pacific Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %)
Figure 104 Asia Pacific Next Generation Sequencing Market Share Forecast by Workflow, 2024 & 2034 (%)
Figure 105 Asia Pacific Next Generation Sequencing Market Share Forecast by Application, 2024 & 2034 (%)
Figure 106 Asia Pacific Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %)
Figure 107 Asia Pacific Next Generation Sequencing Market Share Forecast by End-use, 2024 & 2034 (%)
Figure 108 Japan Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 109 China Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 110 India Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 111 Australia Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 112 South Korea Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 113 Singapore Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 114 Thailand Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 115 Rest of Asia Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 116 Latin America Next Generation Sequencing Market Attractiveness Index
Figure 117 Latin America Next Generation Sequencing Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 118 Latin America Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 119 Latin America Next Generation Sequencing Market Share Forecast by Country, 2024 & 2034 (%)
Figure 120 Latin America Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 121 Latin America Next Generation Sequencing Market Share Forecast by Type, 2024 & 2034 (%)
Figure 122 Latin America Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %)
Figure 123 Latin America Next Generation Sequencing Market Share Forecast by Workflow, 2024 & 2034 (%)
Figure 124 Latin America Next Generation Sequencing Market Share Forecast by Application, 2024 & 2034 (%)
Figure 125 Latin America Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %)
Figure 126 Latin America Next Generation Sequencing Market Share Forecast by End-use, 2024 & 2034 (%)
Figure 127 Brazil Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 128 Mexico Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 129 Argentina Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 130 Colombia Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 131 Rest of Latin America Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 132 MEA Next Generation Sequencing Market Attractiveness Index
Figure 133 MEA Next Generation Sequencing Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 134 MEA Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 135 MEA Next Generation Sequencing Market Share Forecast by Country, 2024 & 2034 (%)
Figure 136 MEA Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 137 MEA Next Generation Sequencing Market Share Forecast by Type, 2024 & 2034 (%)
Figure 138 MEA Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %)
Figure 139 MEA Next Generation Sequencing Market Share Forecast by Workflow, 2024 & 2034 (%)
Figure 140 MEA Next Generation Sequencing Market Share Forecast by Application, 2024 & 2034 (%)
Figure 141 MEA Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %)
Figure 142 MEA Next Generation Sequencing Market Share Forecast by End-use, 2024 & 2034 (%)
Figure 143 GCC Countries Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 144 South Africa Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 145 Turkey Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 146 Rest of MEA Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 147 Next Generation Sequencing Market: Company Share/Ranking, 2023
Figure 148 Illumina, Inc.: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 149 Illumina, Inc.: R&D, 2019-2023 (US$ Million, AGR %)
Figure 150 Illumina, Inc.: Business Segment Market Shares, 2023
Figure 151 Illumina Inc: Regional Market Shares, 2023
Figure 152 Illumina Inc.: SWOT Analysis
Figure 153 Hoffmann-La Roche Ltd.: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 154 Hoffmann-La Roche Ltd.: R&D, 2019-2023 (US$ Million, AGR %)
Figure 155 Hoffmann-La Roche Ltd.: Business Segment Market Shares, 2023
Figure 156 F. Hoffmann-La Roche Ltd.: SWOT Analysis
Figure 157 QIAGEN: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 158 Qiagen: Business Segment Market Shares, 2023
Figure 159 QIAGEN: Regional Market Shares, 2023
Figure 160 QIAGEN: SWOT Analysis
Figure 161 Thermo Fisher Scientific Inc.: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 162 Thermo Fisher Scientific Inc.: Business Segment Market Shares, 2023
Figure 163 Thermo Fisher Scientific Inc.: Regional Market Shares, 2023
Figure 164 Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 165 Bio-Rad Laboratories, Inc.: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 166 Bio-Rad Laboratories, Inc.: Regional Market Shares, 2023
Figure 167 Bio-Rad Laboratories, Inc.: Business Segment Market Shares, 2023
Figure 168 Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 169 PerkinElmer Inc.: SWOT Analysis
Figure 170 Eurofins Scientific: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 171 Eurofins Scientific: Regional Market Shares, 2023
Figure 172 Eurofins Scientific: Business Segment Market Shares, 2023
Figure 173 Eurofins Scientific: SWOT Analysis
Figure 174 Tecan Group: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 175 Tecan Group: Regional Market Shares, 2023
Figure 176 Tecan Group: Business Segment Market Shares, 2023
Figure 177 Takara Bio: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 178 Takara Bio: R&D, 2018-2022 (US$ Million, AGR %)
Figure 179 Takara Bio: Regional Market Shares, 2023
Figure 180 Takara Bio: Business Segment Market Shares, 2023
Figure 181 10x Genomics: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 182 10x Genomics: Business Segment Market Shares, 2023
Figure 183 10x Genomics: Region Market Shares, 2023
Figure 184 GenScript: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 185 Oxford Nanopore: Net Revenue, 2019-2023 (US$ Million, AGR %)

Companies Mentioned

  • Agilent Technologies
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific
  • F. Hoffman-La Roche Ltd.
  • GenScript
  • Illumina, Inc.
  • Integrated DNA Technologies
  • Oxford Nanopore Technologies
  • Perkin Elmer, Inc.
  • QIAGEN
  • Takara Bio
  • Tecan
  • Thermo Fisher Scientific Inc.
  • 10x Genomics
  • AstraZeneca
  • BioLegend
  • Genes2Me
  • Invitae
  • LabCorp
  • Nashville Biosciences
  • Pfizer
  • Quantabio
  • Resolution Bioscience Inc.
  • Theragen Bio
  • Trivitron
  • Brazilian Initiative on Precision Medicine (BIPMed)
  • Genome Canada
  • Genome Institute of Singapore (GIS)
  • Korea National Institute of Health (KNIH)
  • National Genomic Medicine Service (GMS)
  • National Medical Genomics Center (NMGC)
  • National Institutes of Health (NIH)
  • Seoul National University (SNU)

Related Topics

Related Reports

Next-generation Sequencing Data Analysis Market - Product Image

Next-generation Sequencing Data Analysis Market

  • Report
  • 200 Pages
  • Global
From
Clinical Oncology Next-Generation Sequencing Market by Technology, by Workflow, by Application, by End-user, and by Region - Product Image

Clinical Oncology Next-Generation Sequencing Market by Technology, by Workflow, by Application, by End-user, and by Region

  • Report
  • 200 Pages
  • Global
From
Next-Generation Sequencing Sample Preparation Market by Workflow, Application, End User - Global Forecast 2025-2030 - Product Image

Next-Generation Sequencing Sample Preparation Market by Workflow, Application, End User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Next Generation Sequencing Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Opportunity Company Analysis - Product Image

Next Generation Sequencing Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Opportunity Company Analysis

  • Report
  • 235 Pages
  • Global
From
Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End-User, and Region 2024-2032 - Product Image

Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End-User, and Region 2024-2032

  • Report
  • 142 Pages
  • Global
From

About the Market

The Next Generation Sequencing (NGS) market is a subset of the biotechnology industry that focuses on the development and application of high-throughput sequencing technologies. NGS technologies enable the rapid and cost-effective sequencing of large amounts of DNA or RNA, allowing for the analysis of genetic variation and gene expression. This technology has been used to identify and characterize genetic mutations, to study gene expression, and to develop new diagnostics and therapeutics. NGS has also been used to study the evolution of viruses and bacteria, and to identify new species. The NGS market is highly competitive, with a number of companies offering a range of sequencing technologies and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.